Abstract: According to embodiments, a battery includes: a rectangular box-shaped battery case, an inner portion of which is sealed; a battery module housed in the battery case and being an aggregation of a plurality of battery cells; and a tubular heat resistant sheet arranged between the battery case and the battery module in a state of covering an entire side surface of an inner wall surface of the battery case.

Abstract: According to an embodiment, a battery includes: a battery case, an inner portion of which is sealed; a gas discharge portion for gas venting formed in the battery case; a battery module housed in the battery case, the battery module being an aggregation of a plurality of battery cells; a pressure relief portion formed in a part of the battery cell and allowing a vent gas expelled from an inner portion of the battery cell to flow out; and a vent path structure configuring a vent gas path through which the vent gas flows between the pressure relief portion and the gas discharge portion, and a liquid trap portion facilitating liquefaction of the vent gas flowing in the vent gas path and trapping the liquefied liquid.

Abstract: According to embodiments, a battery includes: a rectangular box-shaped battery case, an inner portion of which is sealed; a battery module housed in the battery case and being an aggregation of a plurality of battery cells; and a tubular heat resistant sheet arranged between the battery case and the battery module in a state of covering an entire side surface of an inner wall surface of the battery case.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present invention provides a liposome preparation containing oxaliplatin and derivatized with a hydrophilic polymer and a ligand. In one embodiment the hydrophilic polymer is polyethylene glycol and the ligand is transferrin. In accordance with the invention, the uptake of a pharmaceutical agent contained in the liposome into tumor cells can be enhanced through transferrin receptors expressed on the surface of the tumor cells. Also provided are pharmaceutical compositions containing the liposomes and methods of their use.

Abstract: The present invention provides a liposome preparation containing oxaliplatin and derivatized with a hydrophilic polymer, as well as a pharmaceutical composition for treatment of tumor comprising the liposome preparation. The liposome preparation according to the present invention is characterized in that it is derivatized with a ligand. The ligand is preferably transferrin. In accordance with the invention, the uptake of a pharmaceutical agent in the liposome into tumor cells can be enhanced through transferrin receptors expressed on the surface of the tumor cells.